
HEALTHCARE PROVIDER WEBINAR
X-Linked Hypophosphatemia (XLH): Healthcare Provider Webinar
X-linked hypophosphatemia (XLH) is a rare genetic disorder that affects bone and dental health. It is characterized by low levels of the mineral phosphorus (sometimes referred to as “phosphate”) in the blood due to abnormal processing by the kidneys.
Healthcare providers are invited to join Dr. Angela Cheung on March 20th for a webinar where she will discuss what XLH is, the cause and symptoms, how to test for and diagnose the disease, prognosis and how to support patients.

Webinar Details
Date: Thursday, March 20th, 2025
Time:
2:00 pm – 3:00 pm PT
3:00 pm – 4:00 pm MT
4:00 pm – 5:00 pm CT
5:00 pm – 6:00 pm ET
6:00 pm – 7:00 pm AT
6:30 pm – 7:30 pm NT
PRESENTER

Angela Cheung MD, PhD, FRCPC
Dr. Angela M. Cheung is Professor of Medicine, KY and Betty Ho Chair in Integrative Medicine at University of Toronto and Senior Physician Scientist at University Health Network. She is the Founding Director of the Osteoporosis Program at University Health Network and the Founding Director of the Centre of Excellence in Skeletal Health Assessment at University of Toronto. She obtained her MD from Johns Hopkins University in 1988 and her PhD from Harvard University in 1997. She is a Fellow of the Royal College of Physicians of Canada and has been in clinical practice for >30 years.
She has won many research, teaching and mentorship awards over the years, including the 2024 ASBMR Gideon Rodan’s Mentorship Award, the 2023 European Calcified Tissue Society (ECTS) Research Excellence Award, Canadian Institutes of Health Research (CIHR) Senior Investigator award, Canadian Society of Internal Medicine (CSIM) Dr. David Sackett Senior Investigator Award, Ontario Premier Research Excellence Award, University of Toronto (U of T) Eaton Scholar Award in Clinical Research, University Health Network (UHN) Excellence in Clinical Teaching award, U of T Eudenie Stuart Mentorship award and UHN/Sinai Health System Michael Hutcheon Mentorship award. She currently holds a Tier 1 Canada Research Chair in Postmenopausal and Musculoskeletal Health.
Dr. Cheung was the past chair of Osteoporosis Canada Scientific Advisory Council. She is a current member of the International Osteoporosis Foundation Council of Scientific Advisors and the President-Elect for International Society of Clinical Densitometry. She has published over 250 peer-reviewed manuscripts and has a h-index of 75. Her research interests are in postmenopausal osteoporosis, atypical femur fractures and rare bone diseases.